亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Association of the Lung Immune Prognostic Index With Immune Checkpoint Inhibitor Outcomes in Patients With Advanced Non–Small Cell Lung Cancer

医学 肺癌 内科学 胃肠病学 回顾性队列研究 肿瘤科 腺癌 性能状态 癌症
作者
Laura Mezquita,Édouard Auclin,Roberto Ferrara,Mélinda Charrier,Jordi Remón,David Planchard,Santiago Ponce,Luis Paz Ares,Laura Leroy,Clarisse Audigier-Valette,Enriqueta Felip,Jorge Zerón-Medina,Pilar Garrido,Solenn Brosseau,Gérard Zalcman,Julien Mazières,Caroline Caramela,J. Lahmar,Julien Adam,Nathalie Chaput
出处
期刊:JAMA Oncology [American Medical Association]
卷期号:4 (3): 351-351 被引量:764
标识
DOI:10.1001/jamaoncol.2017.4771
摘要

Importance

Derived neutrophils/(leukocytes minus neutrophils) ratio (dNLR) and lactate dehydrogenase (LDH) level have been correlated with immune checkpoint inhibitor (ICI) outcomes in patients with melanoma.

Objective

To determine whether pretreatment dNLR and LDH are associated with resistance to ICIs in patients with advanced non–small cell lung cancer (NSCLC).

Design, Setting, and Participants

Multicenter retrospective study with a test (n = 161) and a validation set (n = 305) treated with programmed death 1/programmed death ligand 1 (PD-1/PD-L1) inhibitors in 8 European centers, and a control cohort (n = 162) treated with chemotherapy only. Complete blood cell counts, LDH, and albumin levels were measured before ICI treatment. A lung immune prognostic index (LIPI) based on dNLR greater than 3 and LDH greater than upper limit of normal (ULN) was developed, characterizing 3 groups (good, 0 factors; intermediate, 1 factor; poor, 2 factors).

Main Outcomes and Measures

The primary end point was overall survival (OS). Secondary end points were progression-free survival (PFS) and disease control rate (DCR).

Results

In the pooled ICI cohort (N = 466), 301 patients (65%) were male, 422 (90%) were current or former smokers, and 401 (87%) had performance status of 1 or less; median age at diagnosis was 62 (range, 29-86) years; 270 (58%) had adenocarcinoma and 159 (34%) had squamous histologic subtype. Among 129 patients with PD-L1 data, 96 (74%) had PD-L1 of at least 1% by immunohistochemical analysis, and 33 (26%) had negative results. In the test cohort, median PFS and OS were 3 (95% CI, 2-4) and 10 (95% CI, 8-13) months, respectively. A dNLR greater than 3 and LDH greater than ULN were independently associated with OS (hazard ratio [HR] 2.22; 95% CI, 1.23-4.01 and HR, 2.51; 95% CI, 1.32-4.76, respectively). Median OS for poor, intermediate, and good LIPI was 3 months (95% CI, 1 month to not reached [NR]), 10 months (95% CI, 8 months to NR), and 34 months (95% CI, 17 months to NR), respectively, and median PFS was 2.0 (95% CI, 1.7-4.0), 3.7 (95% CI, 3.0-4.8), and 6.3 (95% CI, 5.0-8.0) months (bothP < .001). Disease control rate was also correlated with dNLR greater than 3 and LDH greater than ULN. Results were reproducible in the ICI validation cohort for OS, PFS, and DCR, but were nonsignificant in the chemotherapy cohort.

Conclusions and Relevance

Pretreatment LIPI, combining dNLR greater than 3 and LDH greater than ULN, was correlated with worse outcomes for ICI, but not for chemotherapy, suggesting that LIPI can serve as a potentially useful tool when selecting ICI treatment, raising the hypothesis that the LIPI might be useful for identifying patients unlikely to benefit from treatment with an ICI.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
yxl完成签到,获得积分10
1秒前
可耐的盈完成签到,获得积分10
8秒前
绿毛水怪完成签到,获得积分10
14秒前
lsc完成签到,获得积分10
20秒前
成就迎波完成签到,获得积分10
21秒前
单纯的咖啡豆完成签到,获得积分10
26秒前
小fei完成签到,获得积分10
27秒前
李睿杰完成签到,获得积分10
30秒前
白奕完成签到,获得积分10
33秒前
麻辣薯条完成签到,获得积分10
33秒前
清脆晓瑶完成签到,获得积分10
38秒前
时尚身影完成签到,获得积分10
39秒前
44秒前
leoduo完成签到,获得积分0
46秒前
刘刘完成签到,获得积分10
50秒前
如意夏寒完成签到,获得积分10
51秒前
科研通AI6.2的应助被令狐大侠采纳,获得10
52秒前
科研通AI65的应助被令狐大侠采纳,获得10
52秒前
英俊的铭的应助被令狐大侠采纳,获得10
52秒前
科研通AI6.3的应助被令狐大侠采纳,获得10
53秒前
完美世界的应助被令狐大侠采纳,获得10
53秒前
科研通AI6.4的应助被令狐大侠采纳,获得10
53秒前
科研通AI6.2的应助被令狐大侠采纳,获得30
53秒前
53秒前
流苏2完成签到,获得积分10
56秒前
59秒前
1分钟前
colin发布了新的文献求助10
1分钟前
1分钟前
鹏1989完成签到,获得积分10
1分钟前
年轻班完成签到,获得积分10
1分钟前
勤劳晋鹏完成签到,获得积分10
1分钟前
1分钟前
colin发布了新的文献求助10
1分钟前
plusweng完成签到 ,获得积分10
1分钟前
LHY完成签到,获得积分10
1分钟前
炙热白开水完成签到,获得积分20
2分钟前
单薄代珊完成签到,获得积分10
2分钟前
2分钟前
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8185137
求助须知:如何正确求助?哪些是违规求助? 9574052
关于积分的说明 21834063
捐赠科研通 7782589
什么是DOI,文献DOI怎么找? 3434520
关于科研通互助平台的介绍 2558743
邀请新用户注册赠送积分活动 2481206